Druid BioVentures creates and invests in drug candidates with a focus on virtual companies managed by highly experienced drug development professionals.
401 South 2nd Street
Pennsylvania, United States
|2014-12-03||Naurex||Series C - II||$80M||Adams Street Partners, Baxter Ventures, Cowen Private Investments, EcoR1 Capital, Genesys Capital, Goudy Park Capital, H. Lundbeck, Latterell Venture Partners, Northwestern University, PathoCapital, Portola Capital Partners, Sabby Capital, Savitr Capital, and Takeda Ventures|
|2012-12-17||Naurex||Series B||$38M||Adams Street Partners, Baxter Ventures, Genesys Capital, H. Lundbeck, Latterell Venture Partners, Northwestern University, PathoCapital, Savitr Capital, Shire Strategic Investment Group, and Takeda Ventures|
|2011-05-11||Naurex||Series A||$18M||Adams Street Partners, Genesys Capital, Latterell Venture Partners, Lundbeckfond Ventures, PathoCapital, Shire Strategic Investment Group, and Takeda Ventures|
|2011-02-10||Naurex||Debt||$1.1M||PathoCapital, and Portage Venture Partners|